FIELD: ophthalmological products.
SUBSTANCE: following is disclosed: an ophthalmic liquid product contained in a container in which the inner wall surface consists of a resin including polybutylene terephthalate, and the ophthalmic liquid product contains: (A) 0.0005 to 0.005 w/v% dibutylated hydroxytoluene, (B) 0.05 to 0.3 w/v% xanthan gum thickener, (C) 0.01 to 0.1 w/v% one or more nonionic surfactants selected from the group consisting of polysorbate 80, polyoxyethylene hydrogenated castor oil 60 and polyethylene glycol monostearate, and having a pH of 6 to 8. A method of inhibiting the reduction of dibutylated hydroxytoluene is also disclosed.
EFFECT: group of inventions provides an increase in the stabilizing effect of a product containing dibutylhydroxytoluene.
3 cl, 14 tbl, 9 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR STABILIZING DIBUTYLHYDROXYTOLUENE | 2015 |
|
RU2712031C2 |
STABLE IN STORAGE S-ADENOZYL-L-METHIONINE-CONTAINING COMPOSITION OF DRIED YEASTS AND METHOD OF PRODUCTION THEREOF | 2011 |
|
RU2579972C2 |
BLEACHING AGENT AND COMPOSITION FOR SKIN FOR EXTERNAL APPLICATION | 2009 |
|
RU2434634C1 |
OPHTHALMIC COMPOSITION WITH HIGH CONCENTRATION OF OLOPATADINE | 2012 |
|
RU2613715C2 |
COSMETIC COMPOSITION | 2014 |
|
RU2671398C2 |
STABLE AQUEOUS SOLUTION | 2014 |
|
RU2665639C2 |
TOOTH WHITENING | 2013 |
|
RU2662552C2 |
METHOD FOR STABILIZING DIBUTYLHYDROXYTOLUENE | 2015 |
|
RU2690490C2 |
PHARMACEUTICAL COMPOSITION FOR HISTONE DEACETYLASE INHIBITORS | 2011 |
|
RU2625758C2 |
OPHTHALMIC NANOEMULSION COMPOSITION CONTAINING CYCLOSINO AND PREPARATION METHOD THEREOF | 2014 |
|
RU2683271C2 |
Authors
Dates
2023-12-28—Published
2019-05-31—Filed